Livonyx thinSprayThe transfer of pathogens from the hands of healthcare workers to patients is a significant cause of healthcare associated infections, and hand hygiene compliance is a serious challenge in healthcare environments.

Founded in 2016, LivOnyx Inc. is developing an automated rapid hand disinfection system to reduce healthcare associated infections using thinSpray™-- its patented application technology and proprietary antiseptic.

LivOnyx system rapidly inactivates a wide range of pervasive and resistant bacteriaLaboratory studies have demonstrated that the LivOnyx system rapidly inactivates a wide range of pervasive and resistant bacteria as well as robust spores of Clostridium difficile (also called C. diff or C. difficile for short).

 

LivOnyx system has significant potential in public and institutional settingsIn addition, the LivOnyx system has significant potential in public and institutional settings where effective and consistent hand hygiene is needed including commercial kitchens, food preparation facilities, daycare facilities, schools, gyms and cruise lines.

The global hand antiseptic market is forecast to reach $2B in sales by 2024, and there are opportunities to further increase the overall market as this disruptive technology could improve health, effectiveness and compliance.

Next Steps...

For questions or more information please contact us.